Filter
251
Text search:
affective
disorders
Featured
Recommendations
19
New Publications
23
Language
Document type
No document type
202
Studies & Reports
18
Guidelines
16
Manuals
5
Training Material
3
Fact sheets
3
Brochures
2
Resource Platforms
1
Strategic & Response Plan
1
Countries / Regions
Western and Central Europe
10
Russia
6
Kenya
5
Ukraine
5
Global
5
India
4
South Africa
4
Latin America and the Carribbean
4
Eastern Europe
4
Nigeria
3
Ethiopia
3
Cameroon
2
Philippines
2
Zambia
2
Asia
2
Jamaica
2
Liberia
1
Guinea-Bissau
1
USA
1
Ghana
1
Uganda
1
Zimbabwe
1
Haiti
1
Nepal
1
Germany
1
Tanzania
1
Cambodia
1
Bangladesh
1
Singapore
1
Mozambique
1
Botswana
1
Angola
1
Guatemala
1
Sri Lanka
1
West and Central Africa
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Palestine
1
Southern Africa
1
Estonia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
35
Public Health
8
Women & Child Health
3
Capacity Building
1
Clinical Guidelines
1
Toolboxes
Mental Health
199
Disability
10
COVID-19
7
Conflict
3
Refugee
3
HIV
3
Caregiver
3
Planetary Health
2
Ebola & Marburg
1
TB
1
Global Health Education
1
NCDs
1
Environmental Pollution
http://dx.doi.org/10.1016/j.envpol.2013.05.046
The global burden of disease due to mental disorders continues to rise, especially in low- and middle-income countries (LMIC). In addition to causing a large proportion of morbidity, mental disorders
...
Introduction
Chapter A.9
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with practical recommendations based on scientific evidence to assist in the detection and effective treatmen
...
Dissertationsubmitted for the degree of Doctor of Philosophy, Brunel University
Int J Ment Health Syst. 2013 Jan 9;7(1):2. doi: 10.1186/1752-4458-7-2.
Q4: In individuals with long term and/or recurrent psychotic disorders (including schizophrenia), should individuals be maintained on pharmacotherapy indefinitely or withdrawn from treatment in order to allow for the best outcomes?
Developmental disorders
Chapter C.2
2014 Edition
Anxiety disorders
Chapter F.2
Mood disorders
Chapter E.2
Mood disorders
Chapter E.3
2016 edition
Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a signif
...
Anxiety disorders
Chapter F.5
Other disorders
Chapter H.6
Externalising disorders
Chapter D.2
Mood disorders
Chapter E.1
2015 edition
Mood disorders
Chapter E.4
2018 edition
Mental health disorders remain widely under-reported — in our section on Data Quality & Definitions we discuss the challenges of dealing with this data. Figures presented in this entry should be taken as estimates of mental health disorder prevale
...